• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞对肺炎模型中细菌清除的定量影响。

Quantitative impact of neutrophils on bacterial clearance in a murine pneumonia model.

机构信息

Department of Clinical Sciences and Administration, University of Houston College of Pharmacy, 1441 Moursund Street, Houston, TX 77030, USA.

出版信息

Antimicrob Agents Chemother. 2011 Oct;55(10):4601-5. doi: 10.1128/AAC.00508-11. Epub 2011 Aug 1.

DOI:10.1128/AAC.00508-11
PMID:21807974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3186951/
Abstract

The rapid increase in the prevalence of antibiotic-resistant pathogens is a global problem that has challenged our ability to treat serious infections. Currently, clinical decisions on treatment are often based on in vitro susceptibility data. The role of the immune system in combating bacterial infections is unequivocal, but it is not well captured quantitatively. In this study, the impact of neutrophils on bacterial clearance was quantitatively assessed in a murine pneumonia model. In vitro time-growth studies were performed to determine the growth rate constants of Acinetobacter baumannii ATCC BAA 747 and Pseudomonas aeruginosa PAO1. The absolute neutrophil count in mice resulting from different cyclophosphamide preparatory regimens was determined. The dynamic change of bacterial (A. baumannii BAA 747) burden in mice with graded immunosuppression over 24 h was captured by a mathematical model. The fit to the data was satisfactory (r(2) = 0.945). The best-fit maximal kill rate (K(k)) of the bacterial population by neutrophils was 1.743 h(-1), the number of neutrophils necessary for 50% maximal killing was 190.8/μl, and the maximal population size was 1.8 × 10(9) CFU/g, respectively. Using these model parameter estimates, the model predictions were subsequently validated by the bacterial burden change of P. aeruginosa PAO1 at 24 h. A simple mathematical model was proposed to quantify the contribution of neutrophils to bacterial clearance and predict the bacterial growth/suppression in animals. Our results provide a novel framework to link in vitro and in vivo information and may be used to improve clinical treatment of bacterial infections.

摘要

抗生素耐药病原体的迅速增加是一个全球性问题,这对我们治疗严重感染的能力提出了挑战。目前,临床治疗决策通常基于体外药敏数据。免疫系统在对抗细菌感染方面的作用是明确的,但它没有被很好地定量捕捉。在这项研究中,在鼠肺炎模型中定量评估了中性粒细胞对细菌清除的作用。进行了体外时间生长研究,以确定鲍曼不动杆菌 ATCC BAA 747 和铜绿假单胞菌 PAO1 的生长率常数。确定了不同环磷酰胺预备方案导致的小鼠中性粒细胞绝对计数。通过数学模型捕捉了 24 小时内不同程度免疫抑制小鼠中细菌(鲍曼不动杆菌 BAA 747)负荷的动态变化。数据拟合良好(r²=0.945)。中性粒细胞对细菌种群的最佳拟合最大杀伤率(K(k))为 1.743 h(-1),达到 50%最大杀伤所需的中性粒细胞数量为 190.8/μl,最大种群大小为 1.8×10(9) CFU/g。使用这些模型参数估计值,随后通过 24 小时时铜绿假单胞菌 PAO1 的细菌负荷变化验证了模型预测。提出了一个简单的数学模型来定量评估中性粒细胞对细菌清除的贡献,并预测动物体内的细菌生长/抑制情况。我们的结果提供了一个将体外和体内信息联系起来的新框架,可用于改善细菌感染的临床治疗。

相似文献

1
Quantitative impact of neutrophils on bacterial clearance in a murine pneumonia model.中性粒细胞对肺炎模型中细菌清除的定量影响。
Antimicrob Agents Chemother. 2011 Oct;55(10):4601-5. doi: 10.1128/AAC.00508-11. Epub 2011 Aug 1.
2
Vaccination induces rapid protection against bacterial pneumonia via training alveolar macrophage in mice.接种疫苗可通过训练肺泡巨噬细胞在小鼠中快速预防细菌性肺炎。
Elife. 2021 Sep 20;10:e69951. doi: 10.7554/eLife.69951.
3
Interaction of drug- and granulocyte-mediated killing of Pseudomonas aeruginosa in a murine pneumonia model.在小鼠肺炎模型中药物与粒细胞介导的铜绿假单胞菌杀伤作用的相互作用
J Infect Dis. 2014 Oct 15;210(8):1319-24. doi: 10.1093/infdis/jiu237. Epub 2014 Apr 22.
4
High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils.A/J小鼠对呼吸道鲍曼不动杆菌感染的高易感性与中性粒细胞早期肺募集延迟有关。
Microbes Infect. 2009 Oct;11(12):946-55. doi: 10.1016/j.micinf.2009.06.003. Epub 2009 Jun 30.
5
Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.雾化多黏菌素治疗多重耐药鲍曼不动杆菌和铜绿假单胞菌所致肺炎
Clin Infect Dis. 2005 Sep 1;41(5):754-7. doi: 10.1086/432583. Epub 2005 Jul 20.
6
Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.基于药代动力学/药效学的重症监护病房革兰氏阴性菌肺部感染β-内酰胺类治疗方案比较
J Antimicrob Chemother. 2005 Nov;56(5):893-8. doi: 10.1093/jac/dki335. Epub 2005 Sep 14.
7
Pseudomonas aeruginosa rugose small-colony variants evade host clearance, are hyper-inflammatory, and persist in multiple host environments.铜绿假单胞菌粗糙小菌落变异体逃避宿主清除,具有高度炎症性,并在多种宿主环境中持续存在。
PLoS Pathog. 2018 Feb 2;14(2):e1006842. doi: 10.1371/journal.ppat.1006842. eCollection 2018 Feb.
8
New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.在小鼠大腿和肺部感染模型中,对全身性给予多粘菌素治疗铜绿假单胞菌和鲍曼不动杆菌的新的药代动力学/药效学研究:肺部感染中的反应较小。
J Antimicrob Chemother. 2015 Dec;70(12):3291-7. doi: 10.1093/jac/dkv267. Epub 2015 Aug 27.
9
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
10
Loss of mitochondrial protein Fus1 augments host resistance to Acinetobacter baumannii infection.线粒体蛋白 Fus1 的缺失增强了宿主对鲍曼不动杆菌感染的抵抗力。
Infect Immun. 2013 Dec;81(12):4461-9. doi: 10.1128/IAI.00771-13. Epub 2013 Sep 16.

引用本文的文献

1
Multi-strain phage induced clearance of bacterial infections.多菌株噬菌体诱导清除细菌感染。
PLoS Comput Biol. 2025 Feb 4;21(2):e1012793. doi: 10.1371/journal.pcbi.1012793. eCollection 2025 Feb.
2
A hypervirulent Acinetobacter baumannii strain has robust anti-phagocytosis ability.一株高毒力鲍曼不动杆菌具有强大的抗吞噬能力。
BMC Microbiol. 2024 Apr 1;24(1):106. doi: 10.1186/s12866-024-03264-x.
3
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis.抗真菌治疗优化在治疗腹腔内念珠菌病中的药代动力学和药效学考虑因素。
Crit Care. 2023 Nov 20;27(1):449. doi: 10.1186/s13054-023-04742-w.
4
Model-based assessment of neutrophil-mediated phagocytosis and digestion of bacteria across in vitro and in vivo studies.基于模型的评估:中性粒细胞介导的细菌吞噬和消化作用在体外和体内研究中的差异。
CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):1972-1987. doi: 10.1002/psp4.13046. Epub 2023 Oct 16.
5
The Current Status and Future Perspectives of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients.β-内酰胺类药物在危重症患者中治疗药物监测的现状与未来展望
Antibiotics (Basel). 2023 Mar 30;12(4):681. doi: 10.3390/antibiotics12040681.
6
Hyaluronic acid association with bacterial, fungal and viral infections: Can hyaluronic acid be used as an antimicrobial polymer for biomedical and pharmaceutical applications?透明质酸与细菌、真菌及病毒感染的关联:透明质酸能否用作生物医学和制药应用中的抗菌聚合物?
Bioact Mater. 2022 May 2;19:458-473. doi: 10.1016/j.bioactmat.2022.04.023. eCollection 2023 Jan.
7
Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time-Kill Approaches.预测靶部位的抗菌活性:药代动力学/药效学指标与时间杀菌法
Antibiotics (Basel). 2021 Dec 4;10(12):1485. doi: 10.3390/antibiotics10121485.
8
Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling?为重症患者设定β-内酰胺类药物治疗范围:是否存在下限甚至上限?
Crit Care Explor. 2021 Jun 11;3(6):e0446. doi: 10.1097/CCE.0000000000000446. eCollection 2021 Jun.
9
"NETs and EETs, a Whole Web of Mess".中性粒细胞胞外陷阱与环氧二十碳三烯酸,一团乱麻
Microorganisms. 2020 Dec 4;8(12):1925. doi: 10.3390/microorganisms8121925.
10
Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii.LN-1-255 联合亚胺培南治疗耐碳青霉烯类鲍曼不动杆菌引起的严重感染的疗效。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.01092-19. Print 2019 Oct.

本文引用的文献

1
Risk of mortality in patients with cancer who experience febrile neutropenia.癌症患者中性粒细胞减少性发热的死亡风险。
Cancer. 2010 Dec 1;116(23):5555-63. doi: 10.1002/cncr.25332. Epub 2010 Aug 16.
2
Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes.多重耐药铜绿假单胞菌菌血症对患者结局的影响。
Antimicrob Agents Chemother. 2010 Sep;54(9):3717-22. doi: 10.1128/AAC.00207-10. Epub 2010 Jun 28.
3
Impact of burden on granulocyte clearance of bacteria in a mouse thigh infection model.负担对小鼠大腿感染模型中粒细胞清除细菌的影响。
Antimicrob Agents Chemother. 2010 Oct;54(10):4368-72. doi: 10.1128/AAC.00133-10. Epub 2010 Jun 1.
4
Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge.白细胞介素-10对铜绿假单胞菌攻击后中性粒细胞募集和存活的影响。
Am J Respir Cell Mol Biol. 2009 Jul;41(1):76-84. doi: 10.1165/rcmb.2008-0202OC. Epub 2008 Dec 18.
5
Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia.菌血症患者积极抗菌治疗的延迟与死亡率:严重中性粒细胞减少症的影响
Antimicrob Agents Chemother. 2008 Sep;52(9):3188-94. doi: 10.1128/AAC.01553-07. Epub 2008 Jul 14.
6
Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance.中性粒细胞耗竭会导致小鼠肺部清除金黄色葡萄球菌出现致命缺陷。
J Surg Res. 2008 Dec;150(2):278-85. doi: 10.1016/j.jss.2008.02.009. Epub 2008 Mar 13.
7
Acinetobacter baumannii: a universal threat to public health?鲍曼不动杆菌:对公众健康的普遍威胁?
Int J Antimicrob Agents. 2008 Aug;32(2):106-19. doi: 10.1016/j.ijantimicag.2008.02.013. Epub 2008 Jun 20.
8
Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice.中性粒细胞在小鼠抵御鲍曼不动杆菌呼吸道感染的宿主抵抗力中发挥重要作用。
Infect Immun. 2007 Dec;75(12):5597-608. doi: 10.1128/IAI.00762-07. Epub 2007 Oct 1.
9
Global challenge of multidrug-resistant Acinetobacter baumannii.多重耐药鲍曼不动杆菌的全球挑战
Antimicrob Agents Chemother. 2007 Oct;51(10):3471-84. doi: 10.1128/AAC.01464-06. Epub 2007 Jul 23.
10
The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia.多重耐药性对革兰氏阴性菌肺炎重症患者治疗结果的影响。
Diagn Microbiol Infect Dis. 2007 May;58(1):99-104. doi: 10.1016/j.diagmicrobio.2006.11.014. Epub 2007 Feb 14.